CSCarlos Sánchez-Ovejero

Carlos Sánchez-Ovejero

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Carlos Sánchez-Ovejero has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Recombinant antigen-based multiplex serology for the differential diagnosis of human cestodiases: toward integrated immunoprofiling

    by C. Sánchez-Ovejero, I. Chaves-Coira, A. Rey-Catena

    The serological diagnosis of human cestodiases, particularly cystic echinococcosis (CE) and neurocysticercosis (NCC), is frequently constrained by cross-reactivity associated with crude parasite extracts, limiting its utility in differential diagnosis. This review evaluates the potential of recombinant antigen-based multiplex serology to improve the differentiation between CE and NCC. We examine key diagnostic targets, including the chimeric antigens DIPOL and 2B2t for CE, and T24H together with lentil lectin-adherent glycoproteins (LLGP) for NCC. We further discuss bead-based multiplex platforms that allow the simultaneous detection of antibodies against multiple antigens from a single, small-volume sample. Current evidence indicates that these approaches may reduce cross-reactivity and provide a more nuanced characterisation of pathogen-specific immune responses. Multiplex immunoprofiling represents a promising step toward more integrated serological strategies for the differential diagnosis of human cestodiases. However, further standardisation and validation across diverse epidemiological settings are required prior to routine clinical implementation.

  • Open Access

    Comparison of the multi-epitope recombinant antigen DIPOL and hydatid fluid for the diagnosis of patients with cystic echinococcosis

    by Eylem Akdur Ozturk, Raúl Manzano-Román, Carlos Sánchez-Ovejero, Ayse Caner, Mesude Angın, Cumhur Gunduz, Ülkü Karaman, Nuray Altintas, Halil Bozkaya, Omer Unalp, et al.


  • Open Access

    Evaluation of the recombinant antigens B2t and 2B2t, compared with hydatid fluid, in IgG-ELISA and immunostrips for the diagnosis and follow up of CE patients

    by Ana Hernández-González, Carlos Sánchez-Ovejero, Raúl Manzano-Román, María González Sánchez, José Manuel Delgado, Teresa Pardo-García, Francisco Soriano-Gálvez, Okan Akhan, Carmen M Cretu, Kamenna Vutova, et al.

    Cystic echinococcosis (CE) is one of the most widespread helminthic zoonoses and is caused by the tapeworm Echinococcus granulosus complex. CE diagnosis and monitoring primarily rely on imaging techniques, complemented by serology. This is usually approached by the detection of IgG antibodies against hydatid fluid (HF), but the use of this heterogeneous antigenic mixture results in a variable percentage of false positive and negative results, and has shown to be useless for follow-up due to the long persistence of anti-HF antibodies in cured patients. To improve test performances and standardization, a number of recombinant antigens mainly derived from HF have been described, among them the B2t and 2B2t antigens. The performance of these antigens in the diagnosis and follow up of patients with CE has been so far evaluated on a limited number of samples. Here, we evaluated the performances of tests based on B2t and 2B2t recombinant antigens compared to HF in IgG-ELISA and immunochromatography (IC) for the diagnosis and follow-up of patients with CE in a retrospective cohort study. A total of 721 serum samples were collected: 587 from 253 patients with CE diagnosed by ultrasonography (US), 42 from patients with alveolar echinococcosis and 92 from healthy donors from Salamanca (Spain). The highest overall sensitivity was obtained with HF in ELISA (85.5%), followed by IC containing HF and 2B2t-HF (83.0% and 78.2%, respectively). The lowest sensitivity was obtained with B2t and 2B2t in ELISA (51.8%). The highest specificity was obtained with IC containing 2B2t-HF (100%), and the lowest with HF-ELISA (78.0%). The lowest cross-reactivity with sera from patients with alveolar echinococcosis was detected with the recombinant antigens in ELISA (9.5% - 16.7%) and the highest with the HF-IC (64.3%). The results of B2t and 2B2t-ELISA were influenced by cyst stage, as classified by US according to the WHO-Informal Working Group on Echinococcosis (WHO-IWGE), with low sensitivity for inactive (CE4 and CE5) cysts, and by the drug treatment, with higher sensitivity in patients after drug treatment compared with patients not subjected to drug treatment. The two recombinant antigens in ELISA provided promising results for monitoring patients in follow-up, although their use is limited to patients with positive serology against them at the beginning of the follow-up. Potential biological reasons behind the low sensitivity of the recombinant antigens and possible strategies to enhance the performance of CE serology are discussed. Cystic echinococcosis (CE) is a helminthic zoonosis caused by Echinococcus granulosus sensu lato. CE diagnosis and monitoring is of paramount importance for the clinical management of patients and primarily rely on imaging techniques, complemented by serology. CE serology is usually based on the detection of antibodies against hydatid fluid (HF), but the use of this heterogeneous antigenic mixture shows several drawbacks, including false positive and negative results, unsatisfied predictive values, and long persistence of detectable antibody levels in cured patients. As an alternative, to improve test performances and standardization, several recombinant antigens have been described, but these have been so far evaluated only on a limited number of samples. Here, two recombinant antigens derived from one of the immunodominant HF antigens (antigen B2) have been tested in enzyme-linked immunosorbent assay (ELISA) and in immunochromatographic strips (IC) against 721 serum samples. Although more specific than the HF, the recombinant antigens in ELISA showed low sensitivity for patients with inactive (CE4 and CE5) cysts and for patients not subjected to drug treatment. This limited their use for follow-up, although promising, to those patients with positive serology at the beginning of the follow-up period. These results will aid in the future development of a serological test with enhanced performance in the diagnosis and follow-up of patients with CE.


  • Isolation and characterization of exosomes derived from fertile sheep hydatid cysts

    by Mar Siles-Lucas, Carlos Sánchez-Ovejero, María González-Sánchez, Esperanza González, Juan Manuel Falcón-Pérez, Belgees Boufana, Federica Fratini, Adriano Casulli, Raúl Manzano-Román


  • Top Cited Papers
    Open Access

    Potential Risk Factors Associated with Human Cystic Echinococcosis: Systematic Review and Meta-analysis

    by Alessia Possenti, Raúl Manzano-Román, Carlos Sánchez-Ovejero, Belgees Boufana, Giuseppe La Torre, Mar Siles-Lucas, Adriano Casulli

    Scientific literature on cystic echinococcosis (CE) reporting data on risk factors is limited and to the best of our knowledge, no global evaluation of human CE risk factors has to date been performed. This systematic review (SR) summarizes available data on statistically relevant potential risk factors (PRFs) associated with human CE. Database searches identified 1,367 papers, of which thirty-seven were eligible for inclusion. Of these, eight and twenty-nine were case-control and cross-sectional studies, respectively. Among the eligible papers, twenty-one were included in the meta-analyses. Pooled odds ratio (OR) were used as a measure of effect and separately analysed for the two study designs. PRFs derived from case-control studies that were significantly associated with higher odds of outcome were “dog free to roam” (OR 5.23; 95% CI 2.45–11.14), “feeding dogs with viscera” (OR 4.69; 95% CI 3.02–7.29), “slaughter at home” (OR 4.67; 95% CI 2.02–10.78) or at “slaughterhouses” (OR 2.7; 95% CI 1.15–6.3), “dog ownership” (OR 3.54; 95% CI 1.27–9.85), “living in rural areas” (OR 1.83; 95% CI 1.16–2.9) and “low income” (OR 1.68; 95% CI 1.02–2.76). Statistically significant PRFs from cross-sectional studies with higher odds of outcome were “age >16 years” (OR 6.08; 95% CI 4.05–9.13), “living in rural areas” (OR 2.26; 95% CI 1.41–3.61), “being female” (OR 1.38; 95% CI 1.06–1.8) and “dog ownership” (OR 1.37; 95% CI 1.01–1.86). Living in endemic rural areas, in which free roaming dogs have access to offal and being a dog-owner, seem to be among the most significant PRFs for acquiring this parasitic infection. Results of data analysed here may contribute to our understanding of the PRFs for CE and may potentially be useful in planning community interventions aimed at controlling CE in endemic areas. Cystic echinococcosis (CE) is a chronic zoonotic disease causing serious global socio-economic losses in human and animal hosts. Two main aspects make it extremely difficult to study risk factors associated with human CE, the parasite’s unknown and apparently long incubation period which may last for several years, and the predominantly fecal-oral transmission route. This systematic review (SR) summarizes findings from relevant publications on this topic and provides a detailed list of potential risk factors (PRFs) associated with CE infection in humans. Free dog roaming, dogs having access to offal, being a dog-owner and slaughtering at home or using inadequately supervised slaughterhouses have all been shown to be highly statistically significant PRFs associated with the perpetuation of the parasite life cycle in endemic areas. The effect of other risk factors identified in this SR can vary between geographically different areas and societies and could reflect socio-cultural determinants of infection.


  • Open Access

    Sensing parasites: Proteomic and advanced bio-detection alternatives

    by Carlos Sánchez-Ovejero, Fernando Benito-Lopez, Paula Díez, Adriano Casulli, Mar Siles-Lucas, Manuel Fuentes, Raúl Manzano-Román


  • Open Access

    Serological Diagnosis and Follow-Up of Human Cystic Echinococcosis: A New Hope for the Future?

    by Raúl Manzano-Román, Carlos Sánchez-Ovejero, Ana Hernández-González, Adriano Casulli, Mar Siles-Lucas

    Cystic echinococcosis (CE) is an important helminthic zoonotic disease caused by theEchinococcus granulosuscomplex. In humans, CE is a chronic disease driven by the growth of echinococcal cysts in different organs. Prognosis of this disease depends on multiple factors, including location, number, size, and stage of the cysts, making CE a disease of complex management. CE is usually asymptomatic for years and attracts limited attention from funding organizations and health authorities. For this reason, only experts’ recommendations are available but no evidence-based conclusions have been drawn for CE clinical management. One of those pitfalls refers to the lack of evidence to support the use of serological tools for the diagnosis and follow-up of CE patients. In this respect, crude antigens are used to detect specific antibodies in patients, giving rise to false positive results. The advent of molecular techniques allowing the production of recombinant proteins has provided a number of candidate antigens that could overcome the problems associated with the use of crude parasite extracts in the serological assays. In this review, we present the last advances in this field, proposing the use of serology to support cyst stage-specific diagnosis and follow-up.


  • A diet enriched with mackerel (Scomber scombrus)–derived products improves the endothelial function in a senior population (Prevención de las Enfermedades Cardiovasculares: Estudio Santoña – PECES project)

    by J. M. Gómez de Berrazueta, J. A. Amado Señarís, N. Peña Sarabia, C. Fernández Viadero, M. T. García‐Unzueta, M. Sáez de Adana, C. J. Sanchez Ovejero, J. Llorca

    Background Regular consumption of fish reduces cardiovascular risks. Here, we investigate if the consumption of products with mackerel (Scomber scombrus) with 8·82 g of eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA) content per 100 g of product improves parameters of endothelial function in a controlled population.Materials and methods Subjects maintained a 12‐week diet with products with mackerel. The population consisted of 58 senior subjects (12 withdrawals, 25 women), aged 82·08 ± 8·13 years (Group A). Twenty‐three senior subjects (13 women) on a regular diet were used as the control group (Group B).Subjects of Group A received 57 portions throughout 12 weeks (four to five portions a week of products with a mean EPA + DHA content of 2·5 g a day). A continuous follow‐up and a final evaluation were performed to determine the level of consumption. Plasma samples were stored at –70 °C for a biochemical study. Endothelial function was analysed by reactive hyperemia with a mercury strain gauge plethysmography with measurement of blood flow in the forearm, both baseline and at the end of the 12‐week diet.Results Endothelium‐dependent vasodilatation significantly increased in Group A subjects (P < 0·001). No changes were found in Group B. The subgroup analyses showed that improvements were produced in Group A subjects without cardiovascular disease (P < 0·001). Nitrites/nitrates and von Willebrand factor plasma concentrations were higher in participants after the 12‐week diet.Conclusions The consumption of mackerel meat products improves endothelium‐dependent, flow‐mediated vasodilatation in a senior population. This finding might explain some of the cardioprotective effects of fish consumption.